Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

NCT06841510 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.

NCT NCT06841510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06841510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease
Lead sponsor
Genoss Co., Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
April 19, 2018
Completion date
November 30, 2025
Enrollment
1,118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad)